EU Panel Endorses First-of-Its-Kind Lung Cancer Drug
The first drug to target a KRAS mutation in non-small cell lung cancer (NSCLC) has been recommended for approval in Europe. At its November meeting, …
Home »
The first drug to target a KRAS mutation in non-small cell lung cancer (NSCLC) has been recommended for approval in Europe. At its November meeting, …
The US Food and Drug Administration has approved a new indication for the immunotherapy drug atezolizumab (Tecentriq) — the adjuvant treatment following …
Cancer death rates in the United States continue to decline overall for many common cancers. This decline is particularly prounounced …
NEW YORK (Reuters Health) – More than one-third of lung cancer patients had neuronal autoantibodies that were associated with cognitive …
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TEVATREXED® VERSION 1.0 Pemetrexed disodium Consumer Medicine …
Throughout the world, lung cancer is the main cause of cancer-related deaths. Whereas small cell lung cancer (SCLC) accounts for …
Lung cancer: Signs and symptoms to look out for Lung cancer is one of the most common and serious types …
Lung cancer is one of the most serious types of cancer to be diagnosed, as it’s usually difficult to spot …
Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. Treatment success is largely determined by …
Lung cancer is one of the most serious types of cancer to be diagnosed, as it’s usually difficult to spot …
Lung cancer is mostly caused by smoking, with 72 percent of cases attributed to the unhealthy habit. What recurring health …
New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to …
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can …
Building on their research showing that an exciting new form of immunotherapy for cancer has activity in patients with glioblastoma, …
For years, doctors and scientists have known very little about why patients can receive drugs successfully for months, or even …
Women of color and young women may face elevated risks of developing triple-negative breast cancers, a type of cancer that …
A new study from the University of Pittsburgh Graduate School of Public Health and UPMC Hillman Cancer Center found that …
New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted …